Gary and Mary West Foundation Commits $45 Million to Create …
The News Review:
- Gary and Mary West Foundation Commits $45 Million to Create …
- UCSF Helen Diller Family Comprehensive Cancer Center has Selected …
- Minorities are needed in clinical research
- Lawmakers Detail Medical Research Sting: Company Was a Real Dog
- New Surgery for Heart Failure Proves Ineffective
- Exenatide Clinical Data Analysis Shows No Increased Risk of …
Gary and Mary West Foundation Commits $45 Million to Create …
FXBusiness
“We believe this emerging field will completely transform health care as we know it” said West. “The Institute aims to be the catalyst to move ideas and concepts quickly into reality bringing cost-effective wireless health solutions to doctors patients and their families. Under the leadership of Dr. Topol the Institute and its research team will conduct clinical research on solutions to better prevent diagnose manage and treat major health conditions ranging from Alzheimer’s to heart disease to obesity. The Institute will build a base of biomedical and bioengineering expertise to ensure that devices in development improve the existing level of care and are safe reliable and cost effective. “The rapid and remarkable progress in wireless sensors – continuously tracking important parameters such as blood sugar blood pressure all vital signs sleep state and even caloric intake and expenditure – has the potential to change medicine in a radical and unprecedented way” said Dr.
UCSF Helen Diller Family Comprehensive Cancer Center has Selected …
Trading Markets (press release)
ver one year ago the HDFCCC under the direction of Nadaf initiated a wide-ranging assessment of the centers’ clinical and translational research needs. The center has a heterogeneous and complex clinical research environment. It was clear that in order to improve and expedite performance of the centers’ infrastructure it would be imperative to implement a comprehensive clinical trials management system that was capable of handling the life-cycle activities of any given trial from letter of intent to study close-out.
Related from Gatoradvertisinginformationnetwork: Diller Bearish n ‘09 Advertising
Minorities are needed in clinical research
Rochester Democrat and Chronicle
At some point new knowledge needs to be translated to people and tested in the real world. This requires that volunteers (either healthy individuals or people with the disease or condition that is being studied) step forward and agree to participate in medical research. This research commonly referred to as clinical research can take many forms such as evaluating the safety of a new drug comparing which of two existing treatments is more effective or examining the connection between health behaviors (e. diet and exercise) and certain diseases. Underrepresentation of population groups in health research hampers our ability to develop new ways to understand and treat diseases. We know that disease prevalence varies by population group.
Lawmakers Detail Medical Research Sting: Company Was a Real Dog
Wall Street Journal Blogs
A congressional committee’s sting operation into medical research – one that included a fake company with a fake surgical adhesive to be used in a fake clinical trial – was detailed this morning at a House Energy and Commerce Committee hearing. The hearing focused on the need for more oversight by and of institutional review boards empowered by regulators to decide whether planned clinical research involving humans should be allowed to go ahead. The tale of the surgical adhesive has already been aired in a news release by the IRB in question — Coast IRB of Colorado — which approved the clinical trial five months before learning that the company. Both were created as part of the House committee’s.
New Surgery for Heart Failure Proves Ineffective
U.S. News & World Report
“The use of this type of surgery which has become common in certain [medical] centers should with few exceptions now cease. ” The findings were reported online March 29 in the New England Journal of Medicine to coincide with a presentation of the study at the American College of Cardiology annual meeting in rlando Fla. Jones of the Duke Clinical Research Institute and his colleagues randomly assigned 1000 people with heart failure all participants in the Surgical Treatment for Ischemic Heart Failure (STICH) trial to cardiac bypass surgery alone or bypass surgery plus ventricular reconstruction. Ventricular reconstruction involves making an incision in the damaged part of the left ventricle. After surgeons identify the damaged part they basically sew the healthy part together.
Exenatide Clinical Data Analysis Shows No Increased Risk of …
FXBusiness
This finding suggests there is no increased risk of exenatide on cardiovascular outcomes and will be used to support the cardiovascular safety of exenatide once weekly a phase 3 investigational formulation of exenatide the active ingredient in BYETTA. To determine if there are favorable cardiovascular effects of exenatide treatment Lilly and Amylin intend to initiate a large cardiovascular outcomes trial with a superiority design that will evaluate the effects of exenatide once weekly on major cardiovascular events compared to standard of care with traditional antidiabetes medications. The global study will be sponsored by Amylin and Lilly and active discussions are ongoing to have the study led by two academic research centers The Diabetes Trial Unit at the xford Centre for Diabetes (xford England) and Duke Clinical Research Institute at Duke University (Durham N. The steering committee for this study is chaired by Professor Rury Holman FRCP director Diabetes Trial Unit xford University and Robert M.
Written by admin on March 30th, 2009 with
no comments.
Read more articles on News.